These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 837689)

  • 1. Effects of an anabolic steroid (metandienone) on spermatogenesis.
    Holma PK
    Contraception; 1977 Feb; 15(2):151-62. PubMed ID: 837689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC; Jouannet P; Marson J; Soumah A
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies with cyproterone acetate for male contraception.
    Roy S; Chatterjee S
    J Steroid Biochem; 1979 Jul; 11(1B):675-80. PubMed ID: 491632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation.
    Bastias MC; Kamijo H; Pavlou SN
    Fertil Steril; 1993 Jun; 59(6):1261-5. PubMed ID: 8495775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cyproterone acetate on reproductive functions in normal human males.
    Roy S; Chatterjee S; Prasad MR; Poddar AK; Pandey DC
    Contraception; 1976 Oct; 14(4):403-20. PubMed ID: 975826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antispermatogenic effects of tolnidamine in langur (Presbytis entellus).
    Lohiya NK; Ansari AS; Scorza Barcellona P
    Contraception; 1991 May; 43(5):485-96. PubMed ID: 1914461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers.
    Koch UJ; Lorenz F; Danehl K; Ericsson R; Hasan SH; Keyserlingk DV; Lübke K; Mehring M; Römmler A; Schwartz U; Hammerstein J
    Contraception; 1976 Aug; 14(2):117-35. PubMed ID: 949890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is high dosage testosterone an effective male contraceptive agent?
    Matsumoto AM
    Fertil Steril; 1988 Aug; 50(2):324-8. PubMed ID: 3396702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sperm storage in the human cervix: a quantitative study.
    Insler V; Glezerman M; Zeidel L; Bernstein D; Misgav N
    Fertil Steril; 1980 Mar; 33(3):288-93. PubMed ID: 7364062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA; Yeung CH; Nieschlag E
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin injection, a new contraceptive method: experimental study.
    Shafik A
    Contraception; 1994 Aug; 50(2):191-9. PubMed ID: 7956218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
    Bremner WJ; Bagatell CJ; Steiner RA
    J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of non-aromatizable androgens on testicular and accessory gland functions in rhesus monkeys (Macaca mulatta).
    Ramakrishnan PR; Kaur J; Rajalakshmi M
    J Reprod Fertil; 1990 May; 89(1):69-76. PubMed ID: 2374134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural sperm and aneuploidies studies in a case of spermatogenesis recovery after the use of androgenic anabolic steroids.
    Moretti E; Collodel G; La Marca A; Piomboni P; Scapigliati G; Baccetti B
    J Assist Reprod Genet; 2007 May; 24(5):195-8. PubMed ID: 17342427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.